The Carlyle Group Inc. reported a record-breaking year for 2025, significantly outperforming initial targets with Fee-Related Earnings (FRE) rising 12% year-over-year to a record $1.24 billion and FRE margins expanding to 47%. Assets Under Management (AUM) reached a record $477 billion, driven by $54 billion in inflows (up 32% YoY) and robust investment performance. Distributable Earnings (DE) increased 11% to $1.7 billion ($4.20 per share), supported by record transaction fees of $225 million (+40% YoY) and strong monetization activity, including the landmark Medline IPO. Strategic initiatives in Global Wealth and Credit continued to gain traction, with Evergreen wealth AUM doubling and Global Credit FRE growing 21%. Management expressed strong momentum entering 2026, though they deferred specific financial guidance to an upcoming shareholder update.
| Metric | Value | Change |
|---|---|---|
| Fee-Related Earnings (FRE) | $1.24 billion | +12% YoY |
| FRE Margin | 47% | +100 bps YoY |
| Distributable Earnings (DE) | $1.70 billion | +11% YoY |
| DE per Share | $4.20 | +11% YoY |
| Assets Under Management (AUM) | $477 billion | Record High |
| Inflows | $54 billion | +32% YoY |
| Transaction Fees | $225 million | +40% YoY |
| Deployments | $54 billion | +25% YoY |
| Realized Proceeds | $34 billion | +20% YoY |
| Global Credit FRE | $402 million | +21% YoY |
| AlpInvest FRE | $274 million | +60% YoY |
Global Wealth Expansion: Carlyle is executing a major strategic pivot to capture the individual investor market, a priority initiated three years ago. In 2025, Evergreen wealth AUM more than doubled year-over-year, and the firm soft-launched CPAP, a private equity solution for U.S. individual investors. To support this growth, management expanded the wealth organization headcount by approximately 50% and hired a head of retirement solutions, signaling their conviction that wealth and retirement represent long-term growth engines.
Capital Markets Leadership: The firm successfully countered industry narratives regarding low monetization activity by becoming the number one private equity sponsor globally by IPO proceeds over the past two years, generating roughly $10 billion. This was highlighted by the Medline IPO, which raised over $7 billion at a $49 billion valuation. This success drove transaction fees to a record $225 million (+40% YoY) and demonstrated the firm's ability to navigate public markets effectively.
Credit Platform Diversification: The Global Credit segment demonstrated robust growth and resilience, with FRE increasing 21% to a record $402 million. The firm is actively scaling its direct lending capabilities through key hires, including a new head of direct lending, and maintained a leadership position in CLOs with a record 39 issuances in 2025. This diversification provides stable fee income and positions Carlyle to capture share in the expanding private credit market.
AlpInvest Scale and Growth: Carlyle AlpInvest has emerged as a significant growth driver, generating record FRE of $274 million (up nearly 60%) and record Distributable Earnings of $319 million (up nearly 70%). The segment closed a record $20 billion secondary strategy and deployed a record $14 billion, highlighting the scalability of the platform and its ability to drive substantial earnings accretion through secondary and co-investment strategies.
Macro Fragility and Market Volatility: Despite strong internal metrics, management acknowledged 'fragility' in public markets and recent 'jitters' driven by capital reallocation concerns. CEO Harvey Schwartz noted that while their proprietary portfolio data suggests healthy GDP and EBITDA growth, the markets are experiencing hesitation and spread widening. This external volatility poses a risk to the 'constructive' exit environment and deployment opportunities that underpin their 2026 outlook.
Guidance Opacity: Management repeatedly deflected specific questions regarding 2026 margin expansion, management fee growth, and realization trajectories to an upcoming shareholder update on February 26. While standard for an investor day lead-up, this lack of immediate clarity creates uncertainty regarding the sustainability of current growth rates, particularly as analysts flagged potential headwinds to fee-earning AUM in the upcoming year.
Software Exposure in CLOs: Analysts probed the firm's exposure to software assets within their CLO portfolios amidst a sector sell-off. While management stated their exposure is 'right on top of the index' and not overweight, the sheer volume of their CLO business (record 39 issuances in 2025) means that sector-specific volatility remains a tangible risk factor for their credit earnings.
Reliance on Capital Markets: The firm's record transaction fees and realized proceeds are heavily dependent on a functional IPO and M&A market. Management noted that credit spreads have moved and there is 'hesitation' in the market. If the window for monetizations closes due to macro shocks, the significant revenue contribution from transaction fees (which nearly tripled in two years) could face pressure.
Overall: Management displayed a high degree of confidence and enthusiasm regarding the firm's operational execution and strategic milestones, frequently utilizing superlatives such as 'record' and 'best ever' to describe performance. While acknowledging recent macroeconomic volatility and market fragility, they maintained a constructive tone on the underlying economy and the firm's positioning, emphasizing the durability of their global platform.
Confidence: HIGH - Management consistently cited exceeding targets, record financial metrics, and successful strategic pivots as evidence of their strength. Their deflection of specific 2026 guidance was attributed to a planned strategic update rather than uncertainty, and they expressed strong conviction in their portfolio data and 'all-weather' business model.
Management expects continued growth supported by a diversified fundraising pipeline, expansion in global wealth, and improving capital markets conditions. Specific financial targets were deferred to the February 26 shareholder update.
Management views the macro environment as 'generally constructive' for deployment and realization activity, despite acknowledging recent market fragility and volatility.
Hedging & Uncertainty: Management employed a mix of confident assertions regarding past performance and cautious qualifiers regarding the future. They frequently used phrases like 'reluctant to extrapolate,' 'generally constructive,' and 'I don't want to make near-term market predictions' when discussing macroeconomic conditions. A recurring temporal hedge was the deferral of detailed 2026 guidance to the February 26 shareholder meeting ('We'll go into more detail on the twenty-sixth'), allowing them to maintain a positive outlook without committing to specific numbers amidst current volatility.
2025 was a record year for The Carlyle Group Inc. - Harvey Schwartz, CEO
We significantly outperformed the targets we identified at the beginning of the year. - Harvey Schwartz, CEO
The economic engine feels quite good... But the markets have demonstrated some fragility. - Harvey Schwartz, CEO
We'll go into more detail of that on the twenty-sixth. - Harvey Schwartz, CEO
Our credit business is really an all-weather business. - Justin Plouffe, CFO
We feel quite front-footed... We feel good about the positioning. - Harvey Schwartz, CEO
Analyst Sentiment: Analysts were largely positive, congratulating management on the record results and strong monetization activity. Questions focused heavily on the sustainability of these trends, specifically regarding IPO momentum, credit exposure, and margin expansion.
Management Responses: Management was disciplined in not getting ahead of their scheduled February 26th investor day. They consistently deflected specific quantitative questions about 2026 margins and fee growth to that event, while providing qualitative reassurance about their positioning ('front-footed', 'all-weather business') and the health of their portfolio companies.
Sustainability of monetization/IPO momentum in 2026.
Exposure to software assets within CLO portfolios and credit quality.
Drivers of margin expansion and segment-specific growth outlooks.
Progress and strategy in the Global Wealth channel.
Capital allocation priorities and share buyback program.
Carlyle delivered a stellar performance in 2025, proving the success of its multi-year strategic pivot towards Global Wealth and Credit diversification. The firm achieved record levels across FRE, AUM, and Inflows, demonstrating strong operational leverage and capital return capabilities ($1.2B to shareholders). While management is cautious about short-term macro volatility, the underlying portfolio data suggests resilience. The upcoming shareholder update on Feb 26 is a key catalyst for 2026 targets, but the current momentum and 'all-weather' business mix justify a positive outlook.
Management noted that M&A and IPO activity accelerated in 2025, with credit spreads near all-time tights and equity markets at all-time highs. Carlyle itself was the #1 PE sponsor by IPO proceeds.
Based on proprietary portfolio data, management stated that January data looks 'very good' regarding GDP growth, margins, and EBITDA generation, suggesting the underlying economic engine remains healthy.
Management acknowledged 'fragility' in public markets and recent 'jitters' related to capital spending and reallocation, noting a shift to a 'shoot first ask questions later' mentality in some areas of the market.